{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:59:19Z","timestamp":1761562759582,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA154848","K99CA256038","2T32CA093423","K01CA21845701A1","P30CA016059"],"award-info":[{"award-number":["R01CA154848","K99CA256038","2T32CA093423","K01CA21845701A1","P30CA016059"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002649"],"award-info":[{"award-number":["UL1TR002649"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10549-021-06202-x","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T13:02:32Z","timestamp":1617368552000},"page":"769-778","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardioprotective medication use in Black and white breast cancer survivors"],"prefix":"10.1007","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-0278","authenticated-orcid":false,"given":"Arnethea L.","family":"Sutton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley S.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipankar","family":"Bandyopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reuben","family":"Retnam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William G.","family":"Hundley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa B.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"issue":"1","key":"6202_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10549-018-4723-0","volume":"170","author":"SAM Gernaat","year":"2018","unstructured":"Gernaat SAM, Boer JMA, van den Bongard DHJ, Maas A, van der Pol CC, Bijlsma RM, Grobbee DE, Verkooijen HM, Peeters PH (2018) The risk of cardiovascular disease following breast cancer by Framingham risk score. Breast Cancer Res Treat 170(1):119\u2013127","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"6202_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1097\/GME.0000000000001348","volume":"26","author":"DAB Buttros","year":"2019","unstructured":"Buttros DAB, Branco MT, Orsatti CL, Almeida-Filho BS, Nahas-Neto J, Nahas EAP (2019) High risk for cardiovascular disease in postmenopausal breast cancer survivors. Menopause 26(9):1024\u20131030","journal-title":"Menopause"},{"issue":"3","key":"6202_CR3","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/bcr2901","volume":"13","author":"JL Patnaik","year":"2011","unstructured":"Patnaik JL, Byers T, DiGuiseppi C, Dabelea D, Denberg TD (2011) Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res 13(3):R64","journal-title":"Breast Cancer Res"},{"issue":"3","key":"6202_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ijrobp.2011.08.012","volume":"83","author":"ME Mast","year":"2012","unstructured":"Mast ME, Heijenbrok MW, Petoukhova AL, Scholten AN, Schreur JH, Struikmans H (2012) Preradiotherapy calcium scores of the coronary arteries in a cohort of women with early-stage breast cancer: a comparison with a cohort of healthy women. Int J Radiat Oncol Biol Phys 83(3):853\u2013858","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"6202_CR5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/jnci\/djh253","volume":"96","author":"C Schairer","year":"2004","unstructured":"Schairer C, Mink PJ, Carroll L, Devesa SS (2004) Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst 96(17):1311\u20131321","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"6202_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/CRD.0000000000000252","volume":"27","author":"JB Blanter","year":"2019","unstructured":"Blanter JB, Frishman WH (2019) The Preventive role of angiotensin converting enzyme inhibitors\/angiotensin-II receptor blockers and beta-adrenergic blockers in anthracycline- and trastuzumab-induced cardiotoxicity. Cardiol Rev 27(5):256\u2013259","journal-title":"Cardiol Rev"},{"issue":"9","key":"6202_CR7","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/COC.0000000000000389","volume":"41","author":"S Wittayanukorn","year":"2018","unstructured":"Wittayanukorn S, Qian J, Westrick SC, Billor N, Johnson B, Hansen RA (2018) Prevention of trastuzumab and anthracycline-induced cardiotoxicity using angiotensin-converting enzyme inhibitors or beta-blockers in older adults with breast cancer. Am J Clin Oncol 41(9):909\u2013918","journal-title":"Am J Clin Oncol"},{"issue":"23","key":"6202_CR8","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","volume":"114","author":"D Cardinale","year":"2006","unstructured":"Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M, Martinelli G, Veglia F, Fiorentini C, Cipolla CM (2006) Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 114(23):2474\u20132481","journal-title":"Circulation"},{"issue":"21","key":"6202_CR9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","volume":"37","author":"G Gulati","year":"2016","unstructured":"Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland A, Storas TH et al (2016) Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 \u00d7 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol. Eur Heart J 37(21):1671\u20131680","journal-title":"Eur Heart J"},{"issue":"8","key":"6202_CR10","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/jamaoncol.2016.1726","volume":"2","author":"AH Boekhout","year":"2016","unstructured":"Boekhout AH, Gietema JA, Milojkovic Kerklaan B, van Werkhoven ED, Altena R, Honkoop A, Los M, Smit WM, Nieboer P, Smorenburg CH et al (2016) Angiotensin II-receptor inhibition with candesartan to prevent trastuzumab-related cardiotoxic effects in patients with early breast cancer: a randomized clinical trial. JAMA Oncol 2(8):1030\u20131037","journal-title":"JAMA Oncol"},{"issue":"22","key":"6202_CR11","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.jacc.2019.03.495","volume":"73","author":"M Guglin","year":"2019","unstructured":"Guglin M, Krischer J, Tamura R, Fink A, Bello-Matricaria L, McCaskill-Stevens W, Munster PN (2019) Randomized trial of lisinopril versus carvedilol to prevent trastuzumab cardiotoxicity in patients with breast cancer. J Am Coll Cardiol 73(22):2859\u20132868","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"6202_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1200\/JOP.2016.018770","volume":"13","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Lenihan D (2017) Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract 13(4):270\u2013275","journal-title":"J Oncol Pract"},{"issue":"2","key":"6202_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/tbj.12709","volume":"23","author":"L Gallicchio","year":"2017","unstructured":"Gallicchio L, Calhoun C, Riseberg D, Helzlsouer K (2017) Cardiovascular health among black and white breast cancer patients initiating aromatase inhibitor therapy. Breast J 23(2):206\u2013209","journal-title":"Breast J"},{"issue":"6","key":"6202_CR14","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/ije\/dyz108","volume":"48","author":"AN Troeschel","year":"2019","unstructured":"Troeschel AN, Liu Y, Collin LJ, Bradshaw PT, Ward KC, Gogineni K, McCullough LE (2019) Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer. Int J Epidemiol 48(6):1897\u20131905","journal-title":"Int J Epidemiol"},{"issue":"4","key":"6202_CR15","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s00520-014-2441-7","volume":"23","author":"KB Highland","year":"2015","unstructured":"Highland KB, Hurtado-de-Mendoza A, Stanton CA, Dash C, Sheppard VB (2015) Risk-reduction opportunities in breast cancer survivors: capitalizing on teachable moments. Support Care Cancer 23(4):933\u2013941","journal-title":"Support Care Cancer"},{"issue":"2","key":"6202_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cncr.32342","volume":"126","author":"CC Nocon","year":"2020","unstructured":"Nocon CC, Ajmani GS, Bhayani MK (2020) A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer. Cancer 126(2):381\u2013389","journal-title":"Cancer"},{"key":"6202_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.canep.2018.11.010","volume":"58","author":"JS Hildebrand","year":"2019","unstructured":"Hildebrand JS, Wallace K, Graybill WS, Kelemen LE (2019) Racial disparities in treatment and survival from ovarian cancer. Cancer Epidemiol 58:77\u201382","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"6202_CR18","doi-asserted-by":"publisher","first-page":"e0231599","DOI":"10.1371\/journal.pone.0231599","volume":"15","author":"AC Tramontano","year":"2020","unstructured":"Tramontano AC, Chen Y, Watson TR, Eckel A, Hur C, Kong CY (2020) Racial\/ethnic disparities in colorectal cancer treatment utilization and phase-specific costs, 2000\u20132014. PLoS ONE 15(4):e0231599","journal-title":"PLoS ONE"},{"issue":"9","key":"6202_CR19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/neuonc\/noaa054","volume":"22","author":"N Lamba","year":"2020","unstructured":"Lamba N, Mehanna E, Kearney RB, Catalano PJ, Haas-Kogan DA, Alexander BM, Cagney DN, Lee KA, Aizer AA (2020) Racial disparities in supportive medication use among older patients with brain metastases: a population-based analysis. Neuro Oncol 22(9):1339\u20131347","journal-title":"Neuro Oncol"},{"key":"6202_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jss.2019.07.043","volume":"245","author":"AE Lawrence","year":"2020","unstructured":"Lawrence AE, Deans KJ, Chisolm DJ, Wrona SK, Minneci PC, Cooper JN (2020) Racial disparities in receipt of postoperative opioids after pediatric cholecystectomy. J Surg Res 245:309\u2013314","journal-title":"J Surg Res"},{"issue":"6","key":"6202_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/AOG.0000000000003561","volume":"134","author":"N Badreldin","year":"2019","unstructured":"Badreldin N, Grobman WA, Yee LM (2019) Racial disparities in postpartum pain management. Obstet Gynecol 134(6):1147\u20131153","journal-title":"Obstet Gynecol"},{"issue":"3","key":"6202_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.amjcard.2013.10.010","volume":"113","author":"H Mochari-Greenberger","year":"2014","unstructured":"Mochari-Greenberger H, Liao M, Mosca L (2014) Racial and ethnic differences in statin prescription and clinical outcomes among hospitalized patients with coronary heart disease. Am J Cardiol 113(3):413\u2013417","journal-title":"Am J Cardiol"},{"issue":"2","key":"6202_CR23","first-page":"63","volume":"25","author":"B Briesacher","year":"2003","unstructured":"Briesacher B, Limcangco R, Gaskin D (2003) Racial and ethnic disparities in prescription coverage and medication use. Health Care Financ Rev 25(2):63\u201376","journal-title":"Health Care Financ Rev"},{"key":"6202_CR24","doi-asserted-by":"crossref","unstructured":"Andersen R, Newman JF (2005) Societal and individual determinants of medical care utilization in the United States: societal and individual determinants of medical care utilization. Milbank Q 83(4) (Online-only-Online-only)","DOI":"10.1111\/j.1468-0009.2005.00428.x"},{"issue":"1","key":"6202_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2307\/2137284","volume":"36","author":"RM Andersen","year":"1995","unstructured":"Andersen RM (1995) Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 36(1):1\u201310","journal-title":"J Health Soc Behav"},{"issue":"1","key":"6202_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11764-017-0646-8","volume":"12","author":"VB Sheppard","year":"2018","unstructured":"Sheppard VB, Hurtado-de-Mendoza A, Zheng YL, Wang Y, Graves KD, Lobo T, Xu H, Jennings Y, Tolsma D, Trout M et al (2018) Biospecimen donation among black and white breast cancer survivors: opportunities to promote precision medicine. J Cancer Surviv 12(1):74\u201381","journal-title":"J Cancer Surviv"},{"issue":"3","key":"6202_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.pec.2004.09.005","volume":"57","author":"MMS Wolf","year":"2005","unstructured":"Wolf MMS (2005) Development and validation of the Communication and Attitudinal Self-Efficacy scale for cancer (CASE-cancer). Patient Educ Couns 57(3):333\u2013341","journal-title":"Patient Educ Couns"},{"issue":"3","key":"6202_CR28","first-page":"554","volume":"11","author":"ST Bird","year":"2001","unstructured":"Bird ST, Bogart LM (2001) Perceived race-based and socioeconomic status(SES)-based discrimination in interactions with health care providers. Ethn Dis 11(3):554\u2013563","journal-title":"Ethn Dis"},{"issue":"6","key":"6202_CR29","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/j.1475-6773.2009.01017.x","volume":"44","author":"TA LaVeist","year":"2009","unstructured":"LaVeist TA, Isaac LA, Williams KP (2009) Mistrust of health care organizations is associated with underutilization of health services. Health Serv Res 44(6):2093\u20132105","journal-title":"Health Serv Res"},{"issue":"6","key":"6202_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","volume":"32","author":"CD Sherbourne","year":"1991","unstructured":"Sherbourne CD, Stewart AL (1991) The MOS social support survey. Soc Sci Med 32(6):705\u2013714","journal-title":"Soc Sci Med"},{"issue":"5","key":"6202_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/00005650-199805000-00012","volume":"36","author":"DG Safran","year":"1998","unstructured":"Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, Ware JE (1998) The Primary Care Assessment Survey: tests of data quality and measurement performance. Med Care 36(5):728\u2013739","journal-title":"Med Care"},{"issue":"9","key":"6202_CR32","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/0277-9536(95)00061-B","volume":"41","author":"G Makoul","year":"1995","unstructured":"Makoul G, Arntson P, Schofield T (1995) Health promotion in primary care: physician-patient communication and decision making about prescription medications. Soc Sci Med (1982) 41(9):1241\u20131254","journal-title":"Soc Sci Med (1982)"},{"key":"6202_CR33","unstructured":"Marshall GN (1994) The Patient Satisfaction Questionnaire short-form (PSQ-18). Santa Monica, Calif.: Santa Monica, Calif: RAND"},{"key":"6202_CR34","doi-asserted-by":"crossref","unstructured":"Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol Off J Am Soc Clin Oncol 11(0732-183; 3):570\u2013579","DOI":"10.1200\/JCO.1993.11.3.570"},{"issue":"4","key":"6202_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.12968\/bjon.2011.20.4.220","volume":"20","author":"A Snowden","year":"2011","unstructured":"Snowden A, White CA, Christie Z, Murray E, McGowan C, Scott R (2011) The clinical utility of the distress thermometer: a review. Br J Nurs 20(4):220\u2013227","journal-title":"Br J Nurs"},{"key":"6202_CR36","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/03610928008827941","volume":"A10","author":"DW Hosmer","year":"1980","unstructured":"Hosmer DW, Lemesbow S (1980) A goodness-of-fit test for the multiple logistic regression model. Commun Stat A10:1043\u20131069","journal-title":"Commun Stat"},{"key":"6202_CR37","doi-asserted-by":"crossref","unstructured":"Coughlin SS, Ayyala D, Majeed B, Cortes L, Kapuku G (2020) Cardiovascular disease among breast cancer survivors. Cardiovasc Disord Med 2(1)","DOI":"10.31487\/j.CDM.2020.01.01"},{"issue":"11","key":"6202_CR38","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.jacc.2015.07.021","volume":"66","author":"G Ogedegbe","year":"2015","unstructured":"Ogedegbe G, Shah NR, Phillips C, Goldfeld K, Roy J, Guo Y, Gyamfi J, Torgersen C, Capponi L, Bangalore S (2015) Comparative effectiveness of angiotensin-converting enzyme inhibitor-based treatment on cardiovascular outcomes in hypertensive blacks versus whites. J Am Coll Cardiol 66(11):1224\u20131233","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"6202_CR39","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW et al (2018) 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71(6):e13\u2013e115","journal-title":"Hypertension"},{"issue":"10","key":"6202_CR40","doi-asserted-by":"publisher","first-page":"e00795","DOI":"10.1161\/JAHA.117.007956","volume":"7","author":"JA Luzum","year":"2018","unstructured":"Luzum JA, Peterson E, Li J, She R, Gui H, Liu B, Spertus JA, Pinto YM, Williams LK, Sabbah HN et al (2018) Race and beta-blocker survival benefit in patients with heart failure: an investigation of self-reported race and proportion of African genetic ancestry. J Am Heart Assoc 7(10):e00795","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"6202_CR41","first-page":"264","volume":"92","author":"HY Kim","year":"2017","unstructured":"Kim HY, Jung YJ, Lee SH, Jung HJ, Pak K (2017) Is Beta-Blocker Use Beneficial in Breast Cancer? A Meta-Analysis Oncology 92(5):264\u2013268","journal-title":"A Meta-Analysis Oncology"},{"issue":"25","key":"6202_CR42","doi-asserted-by":"publisher","first-page":"3808","DOI":"10.1200\/JCO.2006.10.4976","volume":"25","author":"MC Pinder","year":"2007","unstructured":"Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25(25):3808\u20133815","journal-title":"J Clin Oncol"},{"issue":"1","key":"6202_CR43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10549-013-2520-3","volume":"139","author":"VB Sheppard","year":"2013","unstructured":"Sheppard VB, Isaacs C, Luta G, Willey SC, Boisvert M, Harper FW, Smith K, Horton S, Liu MC, Jennings Y et al (2013) Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship. Breast Cancer Res Treat 139(1):207\u2013216","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"6202_CR44","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.pec.2017.02.010","volume":"100","author":"AH Christian","year":"2017","unstructured":"Christian AH, O\u2019Malley D, Barac A, Miller SM, Hudson SV (2017) Cardiovascular risk and communication among early stage breast cancer survivors. Patient Educ Couns 100(7):1360\u20131366","journal-title":"Patient Educ Couns"},{"issue":"5","key":"6202_CR45","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1188\/08.ONF.836-843","volume":"35","author":"R Royak-Schaler","year":"2008","unstructured":"Royak-Schaler R, Passmore SR, Gadalla S, Hoy MK, Zhan M, Tkaczuk K, Harper LM, Nicholson PD, Hutchison AP (2008) Exploring patient-physician communication in breast cancer care for African American women following primary treatment. Oncol Nurs Forum 35(5):836\u2013843","journal-title":"Oncol Nurs Forum"},{"issue":"2","key":"6202_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11764-013-0267-9","volume":"7","author":"KE Weaver","year":"2013","unstructured":"Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, Hamilton AS, Oakley-Girvan I, Keel G, Aziz NM (2013) Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 7(2):253\u2013261","journal-title":"J Cancer Surviv"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06202-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-021-06202-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-021-06202-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T06:43:38Z","timestamp":1675147418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-021-06202-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["6202"],"URL":"https:\/\/doi.org\/10.1007\/s10549-021-06202-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"8 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Institutional Review Board at Virginia Commonwealth University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}